Proven Product Program

”The well-known Age-Related Eye Disease Study (AREDS), a large nationwide, placebo-controlled trial, showed that supplementation with certain vitamins and minerals (vitamin C, vitamin E, beta carotene, zinc and copper) reduced the risk of advanced AMD by about 25% over a five-year period compared to placebo. The study involved more than 3,600 adults ages 55 to 80.

”The AREDS study was followed by AREDS2, which tested variations of the original supplement. Instead of beta carotene” (Note: in a Finnish study a couple decades ago, smokers were given a very low level of synthetic beta carotene in isolation and were found to have an increased risk of lung cancer. Carotenoids exist in families in nature not in isolation, which coupled with beta carotenne being synthetic, some scientists believe accounted for the negative result.) ”two other carotenoids with strong links to eye health – lutein and zeaxanthin – were used. This substitution was found to be just as effective as beta carotene and avoided the cancer concern, so AREDS2 supplements use lutein and zeaxanthin. Excerpt from Anti-Aging Nutrition for Eyes, Tufts Health & Nutrition Letter, July 2017.

NeoLife products are not intended to diagnose, treat or cure any disease. (3/2018)